Fibromyalgia (Fibromyalgia Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
The fibromyalgia (fibromyalgia syndrome) pipeline landscape report provides comprehensive information on the therapeutics under development for fibromyalgia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for fibromyalgia (fibromyalgia syndrome) and features dormant and discontinued projects.
What are the key targets in the fibromyalgia pipeline market?
The key targets in the fibromyalgia pipeline market are Cannabinoid Receptor 1, Cannabinoid Receptor 2, 5-Hydroxytryptamine Receptor 2A, 5-Hydroxytryptamine Receptor 2C, Alpha 1 Adrenergic Receptor, Calcitonin Gene Related Peptide, Corticotropin Releasing Factor Receptor, Delta Type Opioid Receptor, DNA Polymerase, Gamma-Aminobutyric Acid Receptor Subunit Alpha 2, (GABA)Gamma-Aminobutyric Acid Receptor Subunit Alpha 3(GABA), Glutamate Ionotropic Receptor NMDA Type Subunit, Histamine H1 Receptor, Kappa Type Opioid Receptor, Monoglyceride Lipase, Mu Type Opioid Receptor, Nociceptin Receptor, Opioid Receptor, Paired Amphipathic Helix Protein Sin3, Prostaglandin G/H Synthase, Prostaglandin G/H Synthase, Sodium Dependent Dopamine Transporter, Sodium Dependent Noradrenaline Transporter, Sodium Dependent Serotonin Transporter, Voltage Dependent N Type Calcium Channel Subunit, Alpha 1B.
Fibromyalgia pipeline products market, by targets
For more target insights, download a free sample
What are the key route of administration of action in the fibromyalgia pipeline market?
The key route of administration of action in the fibromyalgia pipeline market are oral, sublingual, intravenous, subcutaneous, inhalational, nasal, and parenteral.
Fibromyalgia pipeline products market, by route of administration
For more route of administration insights, download a free sample
What are the key molecule type in the fibromyalgia pipeline market?
Small molecule, peptide, live attenuated vaccine, and monoclonal antibody are the key molecule type in the fibromyalgia pipeline market. Small molecule has the highest number of products.
Fibromyalgia pipeline products market, by molecule type
For more molecule type insights, download a free sample
What are the key companies in the fibromyalgia pipeline market?
Some of the key companies in the fibromyalgia pipeline market are One World Cannabis Ltd, Indaptus Therapeutics Inc, Tryp Therapeutics Inc, Aardvark Therapeutics Inc, Aptinyx Inc, Cortene Inc, Engrail Therapeutics Inc, Epitech Group SpA, H. Lundbeck AS, Imbrium Therapeutics LP.
Fibromyalgia pipeline products market, by companies
To know about more key companies, download a free sample
Market report overview
| Key route of administration of action | Oral, Sublingual, Intravenous, Subcutaneous, Inhalational, Nasal, and Parenteral |
| Key targets | Cannabinoid Receptor 1, Cannabinoid Receptor 2, 5-Hydroxytryptamine Receptor 2A, 5-Hydroxytryptamine Receptor 2C, Alpha 1 Adrenergic Receptor, Calcitonin Gene Related Peptide, Corticotropin Releasing Factor Receptor, Delta Type Opioid Receptor, DNA Polymerase, Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 , (GABA)Gamma-Aminobutyric Acid Receptor Subunit Alpha 3(GABA), Glutamate Ionotropic Receptor NMDA Type Subunit, Histamine H1 Receptor, Kappa Type Opioid Receptor, Monoglyceride Lipase, Mu Type Opioid Receptor, Nociceptin Receptor, Opioid Receptor, Paired Amphipathic Helix Protein Sin3, Prostaglandin G/H Synthase, Prostaglandin G/H Synthase, Sodium Dependent Dopamine Transporter, Sodium Dependent Noradrenaline Transporter, Sodium Dependent Serotonin Transporter, Voltage Dependent N Type Calcium Channel Subunit, and Alpha 1B |
| Key molecule type | Small Molecule, Peptide, Live Attenuated Vaccine, and Monoclonal Antibody |
| Key companies | One World Cannabis Ltd, Indaptus Therapeutics Inc, Tryp Therapeutics Inc, Aardvark Therapeutics Inc, Aptinyx Inc, Cortene Inc, Engrail Therapeutics Inc, Epitech Group SpA, H. Lundbeck AS, and Imbrium Therapeutics LP |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Fibromyalgia (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Fibromyalgia (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Fibromyalgia (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Fibromyalgia (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Fibromyalgia (Central Nervous System)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Fibromyalgia (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Fibromyalgia (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Aptinyx Inc
Cortene Inc
Engrail Therapeutics Inc
Epitech Group SpA
H. Lundbeck AS
Imbrium Therapeutics LP
Indaptus Therapeutics Inc
Luye Pharma Group Ltd
One World Cannabis Ltd
PRISM Pharma Co Ltd
Reven Holdings Inc
Shanghai Lvdao Pharmaceutical Technology Co Ltd
Statera Biopharma Inc
Tetra Bio-Pharma Inc
Teva Pharmaceutical Industries Ltd
Tonix Pharmaceuticals Holding Corp
Tryp Therapeutics Inc
Virios Therapeutics, Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the fibromyalgia pipeline products market?
Cannabinoid Receptor 1, Cannabinoid Receptor 2, 5-Hydroxytryptamine Receptor 2A, 5-Hydroxytryptamine Receptor 2C, Alpha 1 Adrenergic Receptor, Calcitonin Gene Related Peptide, Corticotropin Releasing Factor Receptor, Delta Type Opioid Receptor, DNA Polymerase, Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 , (GABA)Gamma-Aminobutyric Acid Receptor Subunit Alpha 3(GABA), Glutamate Ionotropic Receptor NMDA Type Subunit, Histamine H1 Receptor, Kappa Type Opioid Receptor, Monoglyceride Lipase, Mu Type Opioid Receptor, Nociceptin Receptor, Opioid Receptor, Paired Amphipathic Helix Protein Sin3, Prostaglandin G/H Synthase, Prostaglandin G/H Synthase, Sodium Dependent Dopamine Transporter, Sodium Dependent Noradrenaline Transporter, Sodium Dependent Serotonin Transporter, Voltage Dependent N Type Calcium Channel Subunit, and Alpha 1B are the key targets in the fibromyalgia pipeline market.
-
What are the key route of administration of action in the fibromyalgia pipeline products market?
Oral, sublingual, intravenous, subcutaneous, inhalational, nasal, and parenteral are the key route of administration of action in the fibromyalgia pipeline market.
-
What are the key molecule type in the fibromyalgia pipeline products market?
Small molecule, peptide, live attenuated vaccine, monoclonal antibody are the key molecule type in the fibromyalgia pipeline market.
-
What are the key companies in the fibromyalgia pipeline products market?
One World Cannabis Ltd, Indaptus Therapeutics Inc, Tryp Therapeutics Inc, Aardvark Therapeutics Inc, Aptinyx Inc, Cortene Inc, Engrail Therapeutics Inc, Epitech Group SpA, H. Lundbeck AS, Imbrium Therapeutics LP are the key companies in the fibromyalgia pipeline market.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Central Nervous System reports